期刊文献+

单纯性肥胖患者肠促胰岛素分泌激素分泌特点的研究 被引量:1

The changes of secretion mode of incretin in simple obesity
原文传递
导出
摘要 目的比较单纯性肥胖者和正常体重者肠促胰岛素分泌激素的分泌特点。方法选取正常葡萄糖耐量、BMI<24 kg/m2的志愿者10例作为正常对照组,以正常葡萄糖耐量、BMI≥25 kg/m2者7例为肥胖组,均进行75 g葡萄糖负荷,并检测两组受试者的0、15、30、60、90、120 min的血糖、血清胰岛素和血浆胰岛素样多肽1(GLP-1)、葡萄糖依赖促胰岛素分泌肽(GIP),并计算曲线下面积(AUCGLP-1、AUCGIP)。结果肥胖组的血糖峰值升高并后移,胰岛素分泌增加伴高峰后移。肥胖组整体GLP-1分泌水平低于正常组[AUCGLP-1差异有统计学意义(P<0.05)]。肥胖组GIP分泌模式与正常组相似,但血浆水平较正常组升高[AUCGIP差异有统计学意义(P<0.05)]。结论在胰岛素分泌增加、胰岛素抵抗存在的同时,单纯性肥胖者的GLP-1分泌减少,GIP分泌增加。提示两者在单纯性肥胖的病理生理机制中可能发挥着不同的作用。 Objective To compare the secretion of incretin hormones between simple obesity and normal weight healthy people.Methods Selected 10 volunteers with normal glucose tolerance and BMI <24 kg/m2 as control group,7 patients with normal glucose tolerance and BMI≥25 kg/m2 as obesity group.All subjects were detected blood glucose,serum insulin and plasma GLP-1,GIP at 0,15,30,60,90,120 min during oral 75 g glucose tolerance test.Results In obese group,the peak of blood glucose and insulin were elevated and delayed than control group.The plasma GLP-1 level of obese group was significantly lower than normal group(AUCGLP-1 176.0±56.0 vs.335.8±47.0,P=0.038).The GIP secretion pattern was similar between two group,but the GIP plasma levels was higher than that of normal group(AUCGIP 1844.3±260.0 vs.1171.6±152.5,P=0.017).Conclusions The plasma level of GLP-1 is decreased,and accompany with increase secretion of GIP and insulin simultaneously in these simple obesity,they may be to play difference role in the mechanism of obesity.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第23期6981-6985,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 肥胖症 肠抑胃肽 肠促胰岛素分泌激素 胰岛素样多肽1 Obesity Gastric inhibitory polypeptide Incretin hormones Glucagon-like peptide-1
  • 相关文献

参考文献12

  • 1Knop FK,Aaboe K,Vilsboll T,et al.Reduced incretin effect in obese subject with normal glucose tolerance as compared to lean control subjects. Diabetes . 2008
  • 2Heying Z,Yuichiro Y,Katsushi T,et al.Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action. Biochemical and Biophysical Research Communications . 2005
  • 3Knapper JM,Puddicombe SM,Morgan LM,et al.Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagonlikepeptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue. The Journal of Nutrition . 1995
  • 4Song DH,Wolfe MM.Glucose-dependent insulinotropic polypeptide and its role in obesity. Curr Opin Endocrinol Diabetes Obes . 2007
  • 5Patterson JT,Ottaway N,Gelfanov VM,et al.A novel human-based receptor antagonist of sustained action reveals body weight control by endoge-nous GLP-1. ACS Chem Biol . 2011
  • 6Verdich C,Toubro S,Buemann B,Lysgard MJ,Juul HJ,Astrup A.The role of postprandial releases of insulin and incretin hormones in meal-induced satiety: effect of obesity and weight reduction. International Journal of Obesity and Related Metabolic Disorders . 2001
  • 7Eckel RH,Fujimoto WY,Brunzell JD.Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes . 1979
  • 8Osaka T,Endo M,Yamakawa Met al.Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system. Peptides . 2005
  • 9Fukase,N,Igarashi,M,Takahashi,H.Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabetic Medicine . 1993
  • 10Getty-Kaushik L,Song DH,Boylan MOet al.Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity (Silver Spring) . 2006

同被引文献4

  • 1McIntyre,N.,Holdsworth,C.D.,Turner,D.S.New interpretation of oral glucose tolerance. The Lancet . 1964
  • 2Vilsboll T,Krarup T,Deacon CF,Madsbad S,Holst JJ.Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes . 2001
  • 3Drucker DJ,Nauck MA.The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet,The . 2006
  • 4宁光.肠促胰素在血糖稳态调节和2型糖尿病治疗中的作用[J].中华内分泌代谢杂志,2010,26(9):836-839. 被引量:24

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部